MYND ANALYTICS, INC. (OTCMKTS:MYAN) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersItem 5.02.
MYnd Analytics, Inc. (the "Company") previously filed a Current Report on Form 8-K on September 25, 2017 (the "Original Filing") to report that on September 19, 2017, the Board of Directors (the "Board") of the Company elected Peter Unanue as a director, effective immediately. At the time of the Original Filing, the Board had not made a determination regarding any committee assignment for Mr. Unanue. The Company is filing this amended Current Report on Form 8-K/A to report that on November 29, 2017, the Board appointed Mr. Unanue to the Compensation Committee effective on that date.
Other than the preceding disclosure, no other disclosure reported in the Original Filing is amended to this Report.
About MYND ANALYTICS, INC. (OTCMKTS:MYAN)
MYnd Analytics, Inc., formerly CNS Response, Inc., is a cloud-based predictive analytics company that provides objective clinical decision support to mental healthcare providers for the treatment of behavioral disorders, including depression, anxiety, bipolar disorder and post-traumatic stress disorder (PTSD). It uses its neurometric platform, PEER Online, to generate Psychiatric Electroencephalogram, Evaluation Registry Reports to predict the likelihood of response by an individual to certain medications for the treatment of behavioral disorders. The Company’s technology helps in evaluating pharmacotherapy options in patients suffering from non-psychotic behavioral disorders. PEER provides medical professionals with medication sensitivity data for a subject patient based upon the identification and correlation of treatment outcome information from other patients with similar neurophysiologic characteristics. This treatment outcome information is contained in the PEER Online database.
